Menu
No results found.
Weekly Share Price & Valuation Overview
Holley Inc.
Holley Inc. designs, manufactures, and distributes automotive aftermarket products to car and truck enthusiasts primarily in the United States, Canada, and Europe. Its performance automotive products include carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners, and automotive performance plumbing products; and exhaust products, as well as shifters, converters, transmission kits, transmissions, tuners, and automotive software. The company sells its products under the Holley EFI, Holley, MSD, Simpson, EDGE, Superchips, Diablosport, Accel, Flowmaster, and other brands through DTC, E-tailer, warehouse distributor, traditional retailer, automotive platforms, and jobber/installer channels. The company was founded in 1903 and is headquartered in Bowling Green, Kentucky.
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- USD 428.98M
- Enterprise Value Operating value: market cap + total debt − cash.
- USD 952.26M
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- USD 593.80M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- USD 258.04M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- USD 115.07M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- USD 5.00
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- -0.27
- Shares Outstanding
- 120.50M
- Float Shares
- 54.67M
- Implied Shares Outstanding
- 120.50M
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
16.72%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
19.38%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
43.46%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
-5.12%
- ROA Return on assets: net income ÷ total assets.
-
4.84%
- ROE Return on equity: net income ÷ shareholder equity.
-
-6.75%
- Revenue Growth Year-over-year revenue growth.
-
-1.70%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-35.70%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-36.50%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.11
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 1.35
- Total Cash Cash and equivalents.
- USD 63.84M
- Total Debt Short + long-term interest-bearing debt.
- USD 591.02M
- Net Debt Total debt − cash (negative = net cash).
- USD 527.18M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 5.14
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- USD 35.02M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- USD 37.30M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
5.90%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
6.28%
- Cash Conversion (OpCF/EBITDA)
- 0.30
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.